Kang LM, Xu L, Yu FK, Zhang FW, Lang L. Advances in minimally invasive treatment of malignant obstructive jaundice. World J Gastrointest Surg 2024; 16(12): 3650-3654 [DOI: 10.4240/wjgs.v16.i12.3650]
Corresponding Author of This Article
Li-Min Kang, PhD, Doctor, Surgeon, Department of Hepatobiliary and Pancreatic Surgery, Puer People’s Hospital, No. 44 Zhenxing Street, Puer 665000, Yunnan Province, China. kanglimin2010@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3650-3654 Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3650
Advances in minimally invasive treatment of malignant obstructive jaundice
Li-Min Kang, Lei Xu, Fa-Kun Yu, Fu-Wei Zhang, Li Lang
Li-Min Kang, Lei Xu, Fa-Kun Yu, Fu-Wei Zhang, Department of Hepatobiliary and Pancreatic Surgery, Puer People’s Hospital, Puer 665000, Yunnan Province, China
Li Lang, Department of Outpatient, Puer People’s Hospital, Puer 665000, Yunnan Province, China
Author contributions: Kang LM, Xu L, Yu FK, Zhang FW, Lang L designed the overall concept and outline of the manuscript; Kang LM, Xu L, Lang L contributed to writing and editing the manuscript and review of literature; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Li-Min Kang, PhD, Doctor, Surgeon, Department of Hepatobiliary and Pancreatic Surgery, Puer People’s Hospital, No. 44 Zhenxing Street, Puer 665000, Yunnan Province, China. kanglimin2010@163.com
Received: May 19, 2024 Revised: August 22, 2024 Accepted: September 6, 2024 Published online: December 27, 2024 Processing time: 192 Days and 3.7 Hours
Abstract
Malignant obstructive jaundice (MOJ) encompasses a range of diseases stemming from malignant tumors such as cholangiocarcinoma, pancreatic cancer, and primary liver cancer, among others, which cause obstruction in both intra- and extra-hepatic bile ducts. This obstruction may lead to elevated bilirubin levels, hepatic function impairment, and a low rate of successful surgical resection in clinical settings. There are various minimally invasive treatment options for MOJ, including endoscopic biliary drainage, ultrasound-guided procedures, and percutaneous biliary tract puncture drainage.
Core Tip: Malignant obstructive jaundice (MOJ) presents with a subtle onset and poses challenges in early detection. By the time jaundice becomes apparent, the disease has typically advanced to a stage where surgical intervention is no longer feasible. Minimally invasive procedures for jaundice reduction are often the only viable option for the patients, as radical surgery is not feasible. In clinical practice, attention should be paid to the factors such as the underlying cause of MOJ, the degree of bile duct obstruction, the severity of jaundice, the patient’s overall health status and expected prognosis, and the surgical expertise available at the respective medical facility.
